About FANGZHOU JIANKE Company

We are the world's largest online chronic disease management platform. According to CIC data, in terms of the average MAU in 2023, China. We started our business focusing on chronic disease management to meet the needs of people with chronic conditions such as high blood pressure and chronic cardiovascular and respiratory diseases. To meet the needs of patients with chronic diseases in the following areas, we provide comprehensive medical services and online retail pharmacy services through our Jianke platform. Our comprehensive medical services include follow-up doctor consultations and e-prescriptions provided by registered physicians and in-house healthcare professionals through our Hospital-to-Home (“H2H”) service platform. We also provide online retail pharmacy services, providing a broad range of pharmaceuticals and health products directly to our customers. Our comprehensive medical services and online retail pharmacy services are supported by our chronic disease management service centers and a strong pharmaceutical supply chain. Additionally, our platform's large and active user base allows us to effectively connect and interact with doctors and patients, providing them with medical knowledge and content targeted at them. By leveraging these powerful network effects, our platform provides pharmaceutical companies with customized content and marketing solutions to better inform doctors and patients about chronic disease conditions, treatment options, and raise public awareness about diseases. As of December 31, 2023, our chronic disease management service platform had approximately 42.7 million registered users. For the year ended December 31, 2023, our Jianke platform had an average of 8.4 million monthly active users. As of December 31, 2023, the number of registered doctors on our H2H platform reached 212,892. Our registered doctors came from more than 15,600 medical personnel institutions, of which about 58.8% worked for Class III institutions. Hospitals, of which about 38.4% have obtained associate chief physicians or above. Using our chronic disease management platform, we are committed to providing tailored medical care and precision medicine to the community. The number of patients with chronic diseases continues to increase, with a view to expanding our services to a wider range of diseases.